We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A Review of Acquired Autoimmune Blistering Diseases in Inherited Epidermolysis Bullosa: Implications for the Future of Gene Therapy.
- Authors
Patel, Payal M.; Jones, Virginia A.; Behnam, Christy T.; Zenzo, Giovanni Di; Amber, Kyle T.
- Abstract
Gene therapy serves as a promising therapy in the pipeline for treatment of epidermolysis bullosa (EB). However, with great promise, the risk of autoimmunity must be considered. While EB is a group of inherited blistering disorders caused by mutations in various skin proteins, autoimmune blistering diseases (AIBD) have a similar clinical phenotype and are caused by autoantibodies targeting skin antigens. Often, AIBD and EB have the same protein targeted through antibody or mutation, respectively. Moreover, EB patients are also reported to carry anti-skin antibodies of questionable pathogenicity. It has been speculated that activation of autoimmunity is both a consequence and cause of further skin deterioration in EB due to a state of chronic inflammation. Herein, we review the factors that facilitate the initiation of autoimmune and inflammatory responses to help understand the pathogenesis and therapeutic implications of the overlap between EB and AIBD. These may also help explain whether corrections of highly immunogenic portions of protein through gene therapy confers a greater risk towards developing AIBD.
- Subjects
GENE therapy; AUTOIMMUNE diseases; GENETIC disorders; EPIDERMOLYSIS bullosa; SKIN proteins; AUTOANTIBODIES
- Publication
Antibodies (2073-4468), 2021, Vol 10, Issue 2, p19
- ISSN
2073-4468
- Publication type
Article
- DOI
10.3390/antib10020019